The UK government is preparing to introduce tighter controls on the sale of a poison linked to more than 100 suicides in Britain. Ministers have notified bereaved families ahead of a public consultation, planned by the Home Office, on whether to regulate the substance, which currently remains unregulated under existing laws.

The poison in question has been associated with numerous cases of assisted suicide and has gained international attention due to its distribution by Canadian Kenneth Law. Law, 61, who is facing a prison sentence later this year, admitted to 14 counts of aiding suicide in Canada and also acknowledged involvement in approximately 79 deaths in the UK. Despite the gravity of these incidents, no criminal charges have been brought against businesses in the UK that sold the substance, as investigations found that sellers believed their transactions were legitimate.

At present, the poison is subject to reporting requirements under the Poisons Act 1972, meaning sellers must flag suspicious transactions but are not required to hold a licence to sell it. The government is proposing changes that would reclassify the substance to require a Home Office licence for domestic or legitimate foreign sales. This step aims to add a regulatory barrier, potentially reducing easy access to the poison by vulnerable individuals.

Officials acknowledge that regulation would not prevent illegal imports from abroad, such as those facilitated by individuals like Law, but it would control legitimate supply chains within the UK. The poison itself has legitimate uses in certain industries, prompting officials to stress the need for balanced regulation that safeguards public health without unduly restricting lawful business activities.

The planned public consultation forms part of a broader package of reforms to the Poisons Act, reflecting growing concerns over the misuse of toxic substances. A government statement highlighted the importance of implementing appropriate safeguards for dangerous materials to protect the public.

The issue has drawn attention to the challenges authorities face in preventing access to substances used for suicide while respecting their legitimate commercial applications. Support organisations have reminded the public that help is available for those struggling with suicidal thoughts, directing individuals to confidential services such as the Samaritans helpline.